Allspring Global Investments Holdings, LLC Castle Biosciences Inc Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 10,010 shares of CSTL stock, worth $249,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,010

Previous 10,751 6.89%

Holding current value

$249,649

Previous $234,000 21.79%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$17.4 - $31.47 $12,893 - $23,319	-741 Reduced 6.89%	10,010 $285,000
Q2 2024 Jul 26, 2024	SELL	$18.84 - $24.94 $2,091 - $2,768	-111 Reduced 1.02%	10,751 $234,000
Q1 2024 Apr 18, 2024	BUY	$18.06 - $25.3 $92,521 - $129,611	5,123 Added 89.27%	10,862 $240,000
Q4 2023 Jan 25, 2024	BUY	$12.19 - $22.43 $63,253 - $116,389	5,189 Added 943.45%	5,739 $123,000
Q3 2023 Oct 27, 2023	BUY	$13.28 - $20.3 $7,304 - $11,165	550 New	550 $9,000
Q2 2023 Jul 18, 2023	BUY	$11.66 - $26.0 $115,830 - $258,284	9,934 Added 2.7%	378,387 $5.19 Million
Q1 2023 Apr 13, 2023	BUY	$19.47 - $28.49 $304,179 - $445,099	15,623 Added 4.43%	368,453 $8.37 Million
Q4 2022 Jan 23, 2023	BUY	$18.08 - $30.0 $10,631 - $17,640	588 Added 0.17%	352,830 $0
Q3 2022 Oct 26, 2022	SELL	$22.51 - $34.32 $2.62 Million - $4 Million	-116,600 Reduced 24.87%	352,242 $9.19 Million
Q2 2022 Jul 25, 2022	BUY	$16.0 - $45.99 $348,576 - $1 Million	21,786 Added 4.87%	468,842 $10.3 Million
Q1 2022 May 02, 2022	SELL	$33.17 - $46.98 $188,140 - $266,470	-5,672 Reduced 1.25%	447,056 $20.1 Million
Q4 2021 Jan 28, 2022	BUY	$39.06 - $67.58 $17.7 Million - $30.6 Million	452,728 New	452,728 $19.4 Million

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $656M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Castle Biosciences Inc Transaction History